NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
D2V DOSE2VALUE CLINICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
08/13/2024
Trademark type
Combined
Nice classes
35, 42
Filing date
05/17/2023
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/26/2023
First use in commerce
04/26/2023
Drawing code
3
Owner type
03
Owner location
Durham, NC
Examiner
CROSS, TRACY
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the letter "D" formed by squares to the right of two squares aligned vertically with one larger square to the left of the two squares, and the letter "V" on the right with the number two overlapping the letters "D" and "V" in which each character is in an outlined stylized font, and the words "DOSE2VALUE CLINICAL" in smaller font below "D2V".
Holders and representatives
Holders
D2V Inc.
Representatives
Kate A. Sherlock ARCHER & GREINER, P.C.
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialsmanagement and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of biotechnology companies to assist them with clinical researchclinical trials and applications for drug approval
Class 42
Medical and scientific researchconducting clinical trials for others; scientific research in the nature of conducting clinical trials for others
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2024
PUBO
PUBLISHED FOR OPPOSITION
05/28/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/09/2024
GNRT
NON-FINAL ACTION E-MAILED
02/09/2024
CNRT
NON-FINAL ACTION WRITTEN
02/09/2024
DOCK
ASSIGNED TO EXAMINER
02/09/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/17/2023
NWAP
NEW APPLICATION ENTERED
05/20/2023
Continuous trademark protection
Get notified about every new filing that threatens D2V DOSE2VALUE CLINICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.